Why the study?
Although CKD deaths have doubled over two decades, few data exist to inform screening strategies for early CKD detection in low-income and middle-income countries.
Does a point-of-care screening model accurately identify individuals needing confirmatory chronic kidney disease testing in India?
Does a point-of-care screening model accurately identify individuals needing confirmatory chronic kidney disease testing in India?
A simple point-of-care screening model using demographics, anthropometry, and urine dipstick can accurately identify high-risk individuals requiring confirmatory CKD testing in low- and middle-income countries.
Answers are grounded in this paper and cite their sources.
Moderate accuracy supports targeted CKD testing in LMICs; leaves open whether implementation improves detection or outcomes.
Introduction Although deaths due to chronic kidney disease (CKD) have doubled over the past two decades, few data exist to inform screening strategies for early detection of CKD in low-income and middle-income countries. Methods Using data from three population-based surveys in India, we developed a prediction model to identify a target population that could benefit from further CKD testing, after an initial screening implemented during home health visits. Using data from one urban survey (n=8698), we applied stepwise logistic regression to test three models: one comprised of demographics, self-reported medical history, anthropometry and point-of-care (urine dipstick or capillary glucose) tests; one with demographics and self-reported medical history and one with anthropometry and point-of-care tests. The ‘gold-standard’ definition of CKD was an estimated glomerular filtration rate <60 mL/min/1.73 m 2 or urine albumin-to-creatinine ratio ≥30 mg/g. Models were internally validated via bootstrap. The most parsimonious model with comparable performance was externally validated on distinct urban (n=5365) and rural (n=6173) Indian cohorts. Results A model with age, sex, waist circumference, body mass index and urine dipstick had a c-statistic of 0.76 (95% CI 0.75 to 0.78) for predicting need for further CKD testing, with external validation c-statistics of 0.74 and 0.70 in the urban and rural cohorts, respectively. At a probability cut-point of 0.09, sensitivity was 71% (95% CI 68% to 74%) and specificity was 70% (95% CI 69% to 71%). The model captured 71% of persons with CKD and 90% of persons at highest risk of complications from untreated CKD (ie, CKD stage 3A2 and above). Conclusion A point-of-care CKD screening strategy using three simple measures can accurately identify high-risk persons who require confirmatory kidney function testing.
No takes yet. Share an insight, caveat, or question.
Bradshaw et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: